FDA refuses to file BMS treatment over manufacturing concerns
US FDA knocks back BMS and bluebird’s application for ide-cel, demanding further details on CMC portion of BLA.
Archives for May 14, 2020
Biotech launches to create ‘rationally’ designed gene therapy
Kriya Therapeutics launches publicly after raising $80.5m in financing, with three gene therapies in the pipeline.